P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India

Por Kochhar, S, Excler, J, Fast, P
Publicado em 2009

The mechanism of sunlight-mediated inactivation of Bacillus thuringiensis crystals.

Por Pusztai, M, Fast, P, Gringorten, L, Kaplan, H, Lessard, T, Carey, P R
Publicado em 1991

Use of oligonucleotide probes to study the relatedness of delta-endotoxin genes among Bacillus thuringiensis subspecies and strains.

Por Prefontaine, G, Fast, P, Lau, P C, Hefford, M A, Hanna, Z, Brousseau, R
Publicado em 1987

Sexual behavior among volunteers enrolled in a Phase I HIV vaccine trial: experience of Projet San Francisco in Kigali, Rwanda

Por Mukamuyango, J, Karita, E, Bayingana, R, Nyombayire, J, Ingabire, R, Allen, S, Tichacek, A, Fast, P, Price, M, Schmidt, C
Publicado em 2012

Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control

Por Kamali, A, Nsubuga, R N, Ruzagira, E, Bahemuka, U, Asiki, G, Price, M A, Newton, R, Kaleebu, P, Fast, P
Publicado no Sex Transm Infect (2016)

P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients

Por Fast P, Schmidt C, Tichacek A, Grabowski K, Bizimana J, Sebahungu F, Bayingana R, Kayitenkore K, Karita E, Hunter E, Allen S
Publicado em 2009-10-01

P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients

Por Karita, E, Kayitenkore, K, Bayingana, R, Sebahungu, F, Bizimana, J, Grabowski, K, Tichacek, A, Schmidt, C, Fast, P, Hunter, E, Allen, S
Publicado em 2009

Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned

Por Bayingana, R, Nanvubya, A, Karita, E, Nyombayire, J, Ingabire, R, Chinyenze, K, Lehrman, J, Schimidt, C, Hannaman, D, Allen, S, Fast, P
Publicado em 2012

Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda

Por Mpendo, J, Bayingana, R, Nanvubya, A, Karita, E, Ssetaala, A, Kiwanuka, N, Lehrman, J, Schmidt, C, Hannaman, D, Allen, S, Fast, P
Publicado em 2012

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya

Por Mutua, G, Omosa-Manyonyi, G, Park, H, Bergin, P, Laufer, D, Amornkul, PN, Lehrman, J, Fast, P, Gilmour, J, Anzala, O, Farah, B
Publicado em 2012

A mixed-methods assessment of understanding (AoU) tool for AIDS vaccine trials in sub-Saharan Africa: results from a pilot study

Por Lindegger, G, Quayle, M, Singh, S, Welsh, S, Mark, D, Wallace, M, Roux, S, Bekker, L, Mwananyanda, L, Kilembe, W, Chomba, E, Allen, S, Priddy, F, Fast, P
Publicado em 2012

Vaccine responses to conserved regions of the HIV-1 proteome are associated with an increased capacity to inhibit multiple virus isolates ex vivo

Por Ashraf, A, Kopycinski, J, Cheeseman, H, Lala, F, Czyzewska-Khan, J, Spentzou, A, Gill, DK, Keefer, M, Excler, J, Fast, P, Hayes, P, Cox, JH, Gilmour, J
Publicado em 2012

HIV-1 recombinant gp160 vaccine given in accelerated dose schedules

Por Gorse, G. J., Schwartz, D. H., Graham, B. S., Matthews, T. J., Stablein, D. M., Frey, S. E., Belshe, R. B., Clements, M. L., Wright, P. F., Eibl, M., Fast, P. E.
Publicado em 1994

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa

Por Ngongo, BP, Priddy, F, Park, H, Bender, B, Fast, P, Anzala, O, Mutua, G, Ruzagira, E, Kamali, A, Karita, E, Mugo, P, Chomba, E, Bekker, L, Roux, S, Nanvubya, A, Mebrahtu, T
Publicado em 2012

A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis

Por Hassan, A.S., Hare, J., Kamini, G., Yindom, L.M., Kamali, A., Karita, E., Kilemba, W., Price, M.A., Borrow, P., Bjorkman, P., Albert, J., Kaleebu, P., Allan, S., Fast, P., Hunter, E., Gilmour, J., Ndung’u, T., Rowland-Jones, S., Sanders, E.J., Esbjornsson, J.
Publicado no Virus Evol (2017)

OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

Por Vasan, S, Hurley, A, Schlesinger, SJ, Hannaman, D, Gardiner, DF, Dugin, DP, Boente-Carrera, MM, Vittorino, RM, Caskey, M, Andersen, J, Huang, Y, Cox, J, Tarragona, T, Gill, DK, Cheeseman, H, Clark, L, Dally, L, Smith, C, Schmidt, C, Park, H, Sayeed, E, Gilmour, J, Fast, P, Bernard, R, Ho, DD
Publicado em 2009

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Por Agnandji, S.T., Huttner, A., Zinser, M.E., Njuguna, P., Dahlke, C., Fernandes, J.F., Yerly, S., Dayer, J.-A., Kraehling, V., Kasonta, R., Adegnika, A.A., Altfeld, M., Auderset, F., Bache, E.B., Biedenkopf, N., Borregaard, S., Brosnahan, J.S., Burrow, R., Combescure, C., Desmeules, J., Eickmann, M., Fehling, S.K., Finckh, A., Goncalves, A.R., Grobusch, M.P., Hooper, J., Jambrecina, A., Kabwende, A.L., Kaya, G., Kimani, D., Lell, B., Lemaître, B., Lohse, A.W., Massinga-Loembe, M., Matthey, A., Mordmüller, B., Nolting, A., Ogwang, C., Ramharter, M., Schmidt-Chanasit, J., Schmiedel, S., Silvera, P., Stahl, F.R., Staines, H.M., Strecker, T., Stubbe, H.C., Tsofa, B., Zaki, S., Fast, P., Moorthy, V., Kaiser, L., Krishna, S., Becker, S., Kieny, M.-P., Bejon, P., Kremsner, P.G., Addo, M.M., Siegrist, C.-A.
Publicado no N Engl J Med (2015)